Medication adherence and persistence in type 2 diabetes mellitus: perspectives of patients, physicians and pharmacists on the Spanish health care system

被引:21
作者
Labrador Barba, Elena [1 ]
Rodriguez de Miguel, Marta [1 ]
Hernandez-Mijares, Antonio [2 ,3 ]
Javier Alonso-Moreno, Francisco [4 ]
Luisa Orera Pena, Maria [1 ]
Aceituno, Susana [5 ]
Jose Faus Dader, Maria [6 ]
机构
[1] Mylan, Dept Med, Madrid, Spain
[2] Doctor Peset Univ Hosp, Dept Endocrinol & Nutr, Valencia, Spain
[3] Univ Valencia, Dept Med, Valencia, Spain
[4] Ctr Salud Silleria, Dept Primary Hlth Care, Toledo, Spain
[5] Outcomes 10, Castellon de La Plana, Spain
[6] Univ Granada, Dept Biochem & Mol Biol, Fac Pharm, Granada, Spain
来源
PATIENT PREFERENCE AND ADHERENCE | 2017年 / 11卷
关键词
type 2 diabetes mellitus; adherence; persistence; factors; strategies; HOSPITALIZATION; NONADHERENCE; PREVALENCE; MANAGEMENT; MORTALITY; BARRIERS; OUTCOMES; QUALITY; IMPACT;
D O I
10.2147/PPA.S122556
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: A good relationship between diabetes patients and their health care team is crucial to ensure patients' medication adherence and self-management. To this end, we aimed to identify and compare the views of type 2 diabetes mellitus (T2DM) patients, physicians and pharmacists concerning the factors and strategies that may be associated with, or could improve, medication adherence and persistence. Methods: An observational, cross-sectional study was conducted using an electronic self-administered questionnaire comprising 11 questions (5-point Likert scale) concerning factors and strategies related to medication adherence. The survey was designed for T2DM patients and Spanish National Health System professionals. Results: A total of 963 T2DM patients, 998 physicians and 419 pharmacists participated in the study. Overall, a lower proportion of pharmacists considered the proposed factors associated with medication adherence important as compared to patients and physicians. It should be noted that a higher percentage of physicians in comparison to pharmacists perceived that "complexity of medication" (97% vs 76.6%, respectively) and "adverse events" (97.5% vs 72.2%, respectively) were important medication-related factors affecting adherence. In addition, both patients (80.8%) and physicians (80.8%) agreed on the importance of "cost and co-payment" for adherence, whereas only 48.6% of pharmacists considered this factor important. It is also noteworthy that nearly half of patients (43%) agreed that "to adjust medication to activities of daily living" was the best strategy to reduce therapeutic complexity, whereas physicians believed that "reducing the frequency of administration" (47.9%) followed by "reducing the number of tablets" (28.5%) was the most effective strategy to improve patients' adherence. Conclusion: Our results highlight the need for pharmacists to build a stronger relationship with physicians in order to improve patients monitoring and adherence rates. Additionally, these findings may help to incorporate greater patient-centeredness when developing management strategies, focusing on adjusting medication regimens to patients' daily lives.
引用
收藏
页码:707 / 718
页数:12
相关论文
共 50 条
[1]   The perspectives of patients and physicians on the role of pharmacists in improving medication adherence in type 2 diabetes: a qualitative study [J].
Alsairafi, Zahra ;
Waheedi, Mohammad ;
Alsaleh, Fatemah .
PATIENT PREFERENCE AND ADHERENCE, 2019, 13 :1527-1543
[2]   Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review [J].
Kennedy-Martin, Tessa ;
Boye, Kristina S. ;
Peng, Xiaomei .
PATIENT PREFERENCE AND ADHERENCE, 2017, 11 :1103-1117
[3]   Patient-reported outcomes in type 2 diabetes mellitus: patients' and primary care physicians' perspectives in the Spanish health care system [J].
Franch-Nadal, Josep ;
Labrador Barba, Elena ;
Carmen Gomez-Garcia, M. ;
Buil-Cosiales, Pilar ;
Manuel Millaruelo, Jose ;
Orera Pena, Maria Luisa .
PATIENT PREFERENCE AND ADHERENCE, 2015, 9 :1413-1422
[4]   Predictors of medication adherence in patients with type 2 diabetes mellitus [J].
Curkendall, Suellen M. ;
Thomas, Nina ;
Bell, Kelly F. ;
Juneau, Paul L. ;
Weiss, Audrey J. .
CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (10) :1275-1286
[5]   Impact of Medication Adherence and Persistence on Clinical and Economic Outcomes in Patients with Type 2 Diabetes Treated with Liraglutide: A Retrospective Cohort Study [J].
Buysman, Erin K. ;
Liu, Fang ;
Hammer, Mette ;
Langer, Jakob .
ADVANCES IN THERAPY, 2015, 32 (04) :341-355
[6]   Assessment to barriers of medication adherence among patients with Type 2 Diabetes Mellitus [J].
Alfian, Riza ;
Ariani, Novia ;
Nita, Yunita ;
Athiyah, Umi .
JOURNAL OF RESEARCH IN PHARMACY, 2025, 29 (03) :918-927
[7]   Evaluation of home medication review for patients with type 2 diabetes mellitus by community pharmacists: a randomised controlled trial [J].
Rosli, M. Rozaini ;
Neoh, Chin F. ;
Wu, David B. ;
Hassan, Nazariah W. ;
Mahmud, Mahani ;
Rahimi, Afifah ;
Karuppannan, Mahmathi .
PHARMACY PRACTICE-GRANADA, 2021, 19 (03)
[8]   Interprofessional care of patients with type 2 diabetes mellitus in primary care: family physicians' perspectives [J].
Torti, Jacqueline M., I ;
Szafran, Olga ;
Kennett, Sandra L. ;
Bell, Neil R. .
BMC PRIMARY CARE, 2022, 23 (01)
[9]   Medication Adherence in Type 2 Diabetes Patients in Nigeria [J].
Jackson, Idongesit L. ;
Adibe, Maxwell O. ;
Okonta, Matthew J. ;
Ukwe, Chinwe V. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (06) :398-404
[10]   Cardiovascular disease and medication adherence among patients with type 2 diabetes mellitus in an underserved community [J].
McClintock, Heather F. ;
Schatell, Elena T. ;
Bogner, Hillary R. .
BEHAVIORAL MEDICINE, 2022, 48 (01) :31-42